These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 29653190)

  • 21. Resistance Sniffer: An online tool for prediction of drug resistance patterns of Mycobacterium tuberculosis isolates using next generation sequencing data.
    Muzondiwa D; Mutshembele A; Pierneef RE; Reva ON
    Int J Med Microbiol; 2020 Feb; 310(2):151399. PubMed ID: 31980371
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Whole genome sequencing of clinical strains of Mycobacterium tuberculosis from Mumbai, India: A potential tool for determining drug-resistance and strain lineage.
    Chatterjee A; Nilgiriwala K; Saranath D; Rodrigues C; Mistry N
    Tuberculosis (Edinb); 2017 Dec; 107():63-72. PubMed ID: 29050774
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of Mycobacteria Growth Indicator Tube (MGIT) for drug susceptibility testing of Mycobacterium tuberculosis.
    Palomino JC; Traore H; Fissette K; Portaels F
    Int J Tuberc Lung Dis; 1999 Apr; 3(4):344-8. PubMed ID: 10206506
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Whole-Genome Sequencing for Drug Resistance Profile Prediction in
    Gygli SM; Keller PM; Ballif M; Blöchliger N; Hömke R; Reinhard M; Loiseau C; Ritter C; Sander P; Borrell S; Collantes Loo J; Avihingsanon A; Gnokoro J; Yotebieng M; Egger M; Gagneux S; Böttger EC
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30718257
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Whole genome sequencing for the prediction of resistant tuberculosis strains from northern India.
    Saini A; Dadwal R; Yadav R; Kanaujia R; Aggarwal AN; Arora A; Sethi S
    Indian J Med Microbiol; 2024; 48():100537. PubMed ID: 38350525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A precision overview of genomic resistance screening in Ecuadorian isolates of Mycobacterium tuberculosis using web-based bioinformatics tools.
    Morey-León G; Mejía-Ponce PM; Granda Pardo JC; Muñoz-Mawyin K; Fernández-Cadena JC; García-Moreira E; Andrade-Molina D; Licona-Cassani C; Berná L
    PLoS One; 2023; 18(12):e0294670. PubMed ID: 38051742
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical application of testing methods on acid-fast bacteria].
    Ichiyama S; Suzuki K
    Kekkaku; 2005 Feb; 80(2):95-111. PubMed ID: 15920982
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Utility of whole genome sequencing for multidrug resistant Mycobacterium tuberculosis isolates in a reference TB laboratory in New Zealand.
    Basu I; Bower JE; Roberts SA; Henderson G; Aung HL; Cook G; Lowe O; Newton S
    N Z Med J; 2018 Dec; 131(1487):15-22. PubMed ID: 30543607
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Whole Genome Sequencing of Mycobacterium tuberculosis under routine conditions in a high-burden area of multidrug-resistant tuberculosis in Peru.
    Puyén ZM; Santos-Lázaro D; Vigo AN; Cotrina VV; Ruiz-Nizama N; Alarcón MJ; Asto B; Huamán T; Moore DAJ
    PLoS One; 2024; 19(6):e0304130. PubMed ID: 38861531
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular Screening Versus Phenotypic Susceptibility Testing of Multidrug-Resistant Mycobacterium tuberculosis Isolates for Streptomycin and Ethambutol.
    Al-Mutairi NM; Ahmad S; Mokaddas E
    Microb Drug Resist; 2018 Sep; 24(7):923-931. PubMed ID: 29336677
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comprehensive Whole-Genome Sequencing and Reporting of Drug Resistance Profiles on Clinical Cases of Mycobacterium tuberculosis in New York State.
    Shea J; Halse TA; Lapierre P; Shudt M; Kohlerschmidt D; Van Roey P; Limberger R; Taylor J; Escuyer V; Musser KA
    J Clin Microbiol; 2017 Jun; 55(6):1871-1882. PubMed ID: 28381603
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of WGS in Mycobacterium tuberculosis routine diagnosis.
    Cirillo DM; Cabibbe AM; De Filippo MR; Trovato A; Simonetti T; Rossolini GM; Tortoli E
    Int J Mycobacteriol; 2016 Dec; 5 Suppl 1():S252-S253. PubMed ID: 28043590
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The indirect microscopic observation drug susceptibility assay demonstrated high concordance with the indirect MGIT method for pyrazinamide susceptibility testing.
    Wu X; Lu W; Shao Y; Liu Q; Shi X; Wang X; Li C; Zhu L; Chen C
    J Antimicrob Chemother; 2015 Aug; 70(8):2295-9. PubMed ID: 25953803
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modified protocol for drug susceptibility testing of MGIT cultures of Mycobacterium tuberculosis by the MGIT 960.
    Adami AG; Gallo JF; Pinhata JM; Martins MC; Giampaglia CM; de Oliveira RS
    Diagn Microbiol Infect Dis; 2017 Feb; 87(2):108-111. PubMed ID: 27889251
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of Whole-Genome Sequencing for Mycobacterial Species Identification and Drug Susceptibility Testing in a Clinical Setting: a Large-Scale Prospective Assessment of Performance against Line Probe Assays and Phenotyping.
    Quan TP; Bawa Z; Foster D; Walker T; Del Ojo Elias C; Rathod P; ; Iqbal Z; Bradley P; Mowbray J; Walker AS; Crook DW; Wyllie DH; Peto TEA; Smith EG
    J Clin Microbiol; 2018 Feb; 56(2):. PubMed ID: 29167290
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapid identification and susceptibility testing of Mycobacterium tuberculosis from MGIT cultures with luciferase reporter mycobacteriophages.
    Banaiee N; Bobadilla-Del-Valle M; Riska PF; Bardarov S; Small PM; Ponce-de-Leon A; Jacobs WR; Hatfull GF; Sifuentes-Osornio J
    J Med Microbiol; 2003 Jul; 52(Pt 7):557-561. PubMed ID: 12808076
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the BACTEC MGIT 960 system and the resazurin microtiter assay for susceptibility testing of Mycobacterium tuberculosis to second-line drugs.
    Gallo JF; Pinhata JMW; Saraceni CP; de Oliveira RS
    J Microbiol Methods; 2017 Aug; 139():168-171. PubMed ID: 28601653
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Occurrence of disputed rpoB mutations among Mycobacterium tuberculosis isolates phenotypically susceptible to rifampicin in a country with a low incidence of multidrug-resistant tuberculosis.
    Al-Mutairi NM; Ahmad S; Mokaddas E; Eldeen HS; Joseph S
    BMC Infect Dis; 2019 Jan; 19(1):3. PubMed ID: 30606116
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pyrazinamide Susceptibility and
    Rahman A; Ferdous SS; Ahmed S; Rahman SMM; Uddin MKM; Pholwat S; Gratz J; Houpt E; Banu S
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630193
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of a Rapid Molecular Drug-Susceptibility Test for Tuberculosis.
    Xie YL; Chakravorty S; Armstrong DT; Hall SL; Via LE; Song T; Yuan X; Mo X; Zhu H; Xu P; Gao Q; Lee M; Lee J; Smith LE; Chen RY; Joh JS; Cho Y; Liu X; Ruan X; Liang L; Dharan N; Cho SN; Barry CE; Ellner JJ; Dorman SE; Alland D
    N Engl J Med; 2017 Sep; 377(11):1043-1054. PubMed ID: 28902596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.